Walking With Overground Robotic Exoskeleton Device to Increase Behavioral Responsiveness in Patients With Disorders of Consciousness (WALK DOC)

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorSpaulding Rehabilitation Hospital

About this trial

The goal of this observational study is to learn whether walking with an overground robotic exoskeleton (ORE) can improve responsiveness and brain activity in adults with disorders of consciousness (DoC) during inpatient rehabilitation after a severe brain injury. Participants include adults ages 18-70 who are in a coma, unresponsive wakefulness syndrome, or minimally conscious state and are receiving rehabilitation care at Spaulding Rehabilitation Hospital.

The main questions it aims to answer are:

* Does using an ORE improve behavioral responsiveness compared with lying down, sitting, or standing? * Does using an ORE increase brain activity, and are changes in brain activity related to changes in responsiveness? * Is ORE therapy safe, tolerable, and feasible for people with DoC during inpatient rehabilitation?

Researchers will compare participants' responses during sessions involving lying down, sitting, standing, and walking with the robotic exoskeleton to see if the exoskeleton leads to greater improvements in responsiveness and brain activity.

Participants will:

* Complete an initial screening session to determine whether they can safely use the robotic exoskeleton. * Participate in six study sessions over about two weeks during their rehabilitation stay. During these sessions, participants will complete activities that may include lying down, sitting, standing, and walking with a robotic exoskeleton. The order of activities will be assigned at random. * Have their level of responsiveness measured before and after each session using a standardized assessment called the Coma Recovery Scale-Revised (CRS-R). * Wear a wireless EEG cap before, during, and after sessions so researchers can measure brain activity. * Have their heart rate and safety monitored throughout the study sessions.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Medical diagnosis of disorders of consciousness (DoC) confirmed by the Coma Recovery Scale - Revised (CRS-R), including patient classified as Minimally Conscious State (MCS), Unresponsive Wakefulness Syndrome (UWS), or coma.

Acute/Subacute phase of recovery

Medically stable as deemed by a physician

Undergoing medical care and rehabilitation at hospital

Disqualifiers

Concurrent spinal cord injury (SCI)

Degenerative diagnoses, pre-morbid developmental disability, significant psychological diagnosis such as bipolar disorder and schizophrenia

Contracture in the hip, knee and ankle joints.

Uncorrectable Equinovarus foot deformation.

Trial population

The study population will be selected from inpatient rehabilitation patients with disorders of consciousness (DoC) receiving medical care and rehabilitation at inpatient rehabilitation units in an inpatient rehabilitation facility (IRF) or long-term acute care hospital (LTAC). Patients will be identified from those admitted for inpatient rehabilitation and screened using the eligibility criteria outlined, through the hospital's standard clinical and medical record review processes.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Overground Robotic Exoskeleton (ORE)

    Device

    Participants will receive overground robotic exoskeleton-assisted standing and walking as part of inpatient rehabilitation. Following a screening session to assess device fit and tolerance, participants complete supervised ORE sessions. The intervention is distinguished by the use of assisted overground walking and upright mobility in individuals with disorders of consciousness and is evaluated in relation to behavioral responsiveness, brain activity, safety, tolerability, and feasibility.

Treatment groups

18 Participants
are divided into 1 treatment group
Group A: Patients with Disorders of Consciousness1 intervention

Trial outcomes

Primary outcomes

1

Coma Recovery Scale-Revised (CRS-R)

The Coma Recovery Scale-Revised (CRS-R) is a 23-item behavioral assessment used to evaluate consciousness in patients with brain injuries. It measures auditory, visual, motor, oromotor, and communication functions. The total score ranges from a minimum of 0 to a maximum of 23, with higher scores indicating a higher level of neurobehavioral function and conscious awareness. CRS-R scores help characterize a patient's level of consciousness, including coma, vegetative state/unresponsive wakefulness syndrome, or minimally conscious state.

Time frame
From enrollment to end of study at 2 weeks

Secondary outcomes

1

Disability Rating Scale (DRS)

The Disability Rating Scale (DRS) is an 8-item clinical tool used to track a patient's recovery from a moderate-to-severe traumatic brain injury (TBI) from the coma stage through to community living. Scores range from 0 (no disability) to 29 (extreme vegetative state)

Time frame
Discharge from inpatient rehabilitation, an average of 8 weeks
2

CARE (Continuity Assessment Record and Evaluation)

The CARE (Continuity Assessment Record and Evaluation) tool is a standardized CMS assessment used to measure the medical, functional, cognitive, and social needs of Medicare post-acute care patients The assessment evaluates four major domains: * Medical Domain: Monitors changes in severity, active treatments, pain, and pressure ulcers. * Functional Domain: Evaluates self-care and mobility prior to and during the illness (e.g., assessing mobility and daily living activities). * Cognitive Domain: Assesses functional cognition, cognitive impairments, and factors affecting outcomes. * Social/Environmental Factors: Reviews living situations, support systems, and discharge planning needs.

Time frame
From inpatient admission through discharge from inpatient stay, assessed at routine intervals.
3

Electroencephalogram (EEG)

Cortical activity will be recorded continuously during the study sessions using a 24-channel mobile electroencephalography (EEG) system. Key positional changes will be marked in the EEG recording. EEG spectral power, including power within predefined brain wave frequency bands, will be evaluated before, during, and after positional changes. Changes in these measures will be used to evaluate cortical activity across study conditions. EEG frequency measures will be reported in hertz (Hz).

Time frame
Measured throughout 6 study assessment sessions conducted over 2 weeks during inpatient rehabilitation.
4

Event-Related Potential (ERP) - N100

Event-related potentials (ERP) will be recorded before and immediately after each study session. N100 ERP responses will be assessed, reflecting auditory sensory processing. For each response, the timing of the brain response (peak latency) will be measured. ERP latency measures will be reported in milliseconds (ms).

Time frame
Measured throughout 6 study assessment sessions conducted over 2 weeks during inpatient rehabilitation.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: